NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on improving surgical care for neurological disorders, announced today that it will participate in the Planet MicroCap Las Vegas 2026 Conference, taking place June 17-18, 2026.
Dave Rosa, President & Chief Executive Officer, will attend the conference in Las Vegas, NV, where he is scheduled to host one-on-one meetings with institutional investors. On Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time, Mr. Rosa will deliver a company presentation in TRACK 6 - Raphael 3. The presentation will include commercialization updates and anticipated milestones for the OneRF platform, which is designed for treatment of the brain, pain, and advanced drug delivery.
Additionally, Mr. Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference, which can be viewed here. The webcast of the presentation will be available here, and more conference details can be found here.
NeuroOne markets a minimally invasive and high-definition electrode technology platform with four FDA-cleared product families: Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System (for brain), and OneRF Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs.
For more information on NeuroOne, visit nmtc1.com. Caution: Federal law restricts this device to sale by or on the order of a physician.
